| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.9 |